Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

Novartis Investigative Site, Vienna

Novartis Investigative Site, Camperdown

Novartis Investigative Site, Leuven

Novartis Investigative Site, Prahran

Memorial Sloan Kettering Cancer Center Dept. of MSKCC (2), New York

Novartis Investigative Site, Berlin

University of Pennsylvania, Philadelphia

Novartis Investigative Site, Hamburg

Virginia Commonwealth University SC, Richmond

Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia, Augusta

Novartis Investigative Site, Istanbul

Novartis Investigative Site, Cologne

Novartis Investigative Site, Mannheim

Novartis Investigative Site, Paris

Novartis Investigative Site, Amiens

University of California at Los Angeles Dept. of Hematology Clinic, Los Angeles

Oregon Health and Science University Dept. Hematologic Malignancies, Portland

Stanford University Medical Center Stanford University 2, Stanford

Dana Farber Cancer Institute Hematology / Oncology, Boston

University of Michigan Comprehensive Cancer Center DeptofMichiganCancerCenter(3), Ann Arbor

Novartis Investigative Site, London

Novartis Investigative Site, Toronto

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Groningen

Novartis Investigative Site, Oslo

Novartis Investigative Site, Gdansk

Novartis Investigative Site, Glasgow - Scotland

Novartis Investigative Site, Liverpool

Novartis Investigative Site, London